Business Wire

REPLY

4.5.2022 09:32:07 CEST | Business Wire | Press release

Share
REPLY: Enel Enhances the Efficiency of Maintenance Work With Quantum Inspired Algorithms

Reply announced today that it has implemented a Quantum Inspired Algorithm, that can be used on both Quantum and traditional computers, for Enel , one of the leading global operators in the electricity and renewable energy production sector. The innovative solution allows Enel to quickly identify the optimal allocation of maintenance activities for operating units distributed across the areas where it operates.

For Enel, which boasts a presence in over 30 countries around the world, a network of over 2.2 million kilometres and 74 million end users, it is essential to coordinate the crews and the allocation and planning of the objectives of the operating units scattered throughout the various territories to guarantee the highest level of service for its customers. Hence the need for operational planning that is as efficient as possible.

The solution developed by Reply is based on the QUBO (Quadratic Unconstrained Binary Optimisation ) mathematical model and can be performed effectively by quantum hardware, known as Quantum Processing Units or QPUs , as well as by classical hardware, known as Graphics Processing Units or GPUs .

Extracting the maximum potential of the GPUs was possible thanks to the MegaQUBO accelerator, a software solution developed by Data Reply to speed up the implementation of Quantum Inspired Optimisation projects . MegaQUBO is a solution certified by Amazon Web Services for use on the AWS Cloud, through the “FTR - Foundational Technical Review” process, which ensures that the software adheres to AWS architectural best practices.

In addition to identifying the optimal allocation of activities, the algorithm created for Enel is also able to calculate the optimal travel routes to reach work destinations, minimising travel times and distances and maximising the time available for actual maintenance work. This leads to a significant increase in productivity and a substantial reduction in operating costs, as well as the corresponding environmental impact .

“Quantum computing makes it possible to solve challenges considered insurmountable until just a few years ago” comments Filippo Rizzante, CTO of Reply . “As we were able to successfully demonstrate based on our experience with Enel, the use of quantum algorithms to solve optimisation problems allows us to obtain significant benefits, not only in the quality of the results, but also in the reduction of processing times. At Reply, we are thus closely exploring different areas in which we can exploit the potential of quantum computing to obtain insights from extremely large and constantly updated databases.”

“The need to implement optimisation strategies on increasingly large territorial areas has correspondingly enhanced the complexity of the problem, to the point that a new and innovative approach was needed”, explains Fabio Veronese, Head of Infrastructure & Networks Digital Hub at ENEL . “The Quantum Inspired approach implemented together with Reply has made it possible to achieve significant and concrete results in the field, and is applicable to both known problems, as well as to new business contexts.”

Reply

Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on the new communication channels and digital media. Through its network of highly specialised companies, Reply partners with major European corporations in the telecoms and media, industry and services, banking and insurance, and public administration sectors, to devise and develop business models built on the new paradigms of artificial intelligence, big data, cloud computing, digital media, and the Internet of Things. Reply’s services include: Consulting, Systems Integration, and Digital Services. www.reply.com

Data Reply

Data Reply is the Reply group company that specialises in Big Data Analytics, Artificial Intelligence, and Quantum Computing. Thanks to multidisciplinary teams of specialists in Big Data Engineering, Data Science, Intelligent Process Automation, and Quantum & Accelerated Computing, Data Reply supports companies operating in different industrial sectors in their process optimisation journey, through the design and implementation of advanced Quantum Computing solutions and Machine Learning and Artificial Intelligence models. www.data.reply.com

Enel

Enel is the largest European utility by ordinary EBITDA and is present in over 30 countries worldwide, producing energy with around 88 GW of installed capacity. Enel distributes electricity through a network of over 2.2 million kilometres, and with approximately 74 million corporate and domestic end users worldwide, the Group boasts the largest customer base among European competitors. Within the Enel Group, Enel Green Power is the largest private operator in the renewable energy sector in the world, with a managed capacity of over 46 GW from wind, solar, geothermal and hydroelectric plants in Europe, the Americas, Africa, Asia and Oceania. Enel X, Enel’s global advanced energy services business line, is a world leader in demand response, with a total capacity of over 6.3 GW managed globally. The company has installed 110 MW of storage capacity and, in the electric mobility sector, over 100,000 charging points for public and private electric vehicles worldwide.

Link:

ClickThru

Social Media:

https://www.facebook.com/ReplyinUK/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye